Crossmark

Transthyretin amyloid cardiomyopathy

Crossref DOI link: https://doi.org/10.1016/j.medcle.2020.06.033

Published Print: 2021-02

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Garcia-Pavia, Pablo

Domínguez, Fernando

Gonzalez-Lopez, Esther
Funding

Funding for this research was provided by:

Alnylam Pharmaceuticals (PI18/00765, PI20/01379)

Instituto de Salud Carlos III (PI18/00765, PI20/01379)
License Information

Text and Data Mining valid from 2021-02-01
More Information

This article is maintained by: Elsevier

Article Title: Transthyretin amyloid cardiomyopathy

Journal Title: Medicina Clínica (English Edition)

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.medcle.2020.06.033

CrossRef DOI link to the associated document: https://doi.org/10.1016/j.medcli.2020.06.064

Content Type: article

Copyright: © 2020 Elsevier España, S.L.U. All rights reserved.